Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03180840 |
|---|---|
| Brief Title: | Study of the Safety, Efficacy, & PK of Pegunigalsidase Alfa (PRX-102) 2 mg/kg IV Administered Every 4 Weeks in Fabry Disease Patients (BRIGHT) |
| First Submitted : | May 29, 2017 |
| First Submitted that Met QC Criteria : | June 7, 2017 |
| First Posted : | June 8, 2017 |
| Last Update Submitted that Met QC Criteria : | March 29, 2022 |
| Last Update Posted : | April 7, 2022 |